Kotani Kazuhiko, Fujiwara Shinji, Tsuzaki Kokoro, Sano Yoshiko, Nagai Narumi, Yamada Toshiyuki, Sakane Naoki
Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
J Clin Med Res. 2011 Dec;3(6):319-24. doi: 10.4021/jocmr738w. Epub 2011 Nov 10.
Limited studies have shown inconsistent data about the association between the uncoupling protein 1 (UCP1) gene A-3826G polymorphism and high-density lipoprotein (HDL) cholesterol levels. The present study investigated the association between the A-3826G polymorphism and low HDL-cholesterolemia in non-obese and obese subjects.
Anthropometric and biochemical factors, in addition to genotyping by an allele-specific DNA assay, were measured in 294 community-dwelling Japanese subjects (male/female: 127/167, mean age: 65 years). Obesity was defined as a body mass index (BMI) ≥ 25 kg/m(2), and low HDL-cholesterolemia was defined as < 1.04 mmol/L of HDL-cholesterol.
The subjects with the G/G genotype (n = 27) showed a significantly higher prevalence of low HDL-cholesterolemia (37%) than those with the A/A + A/G genotype (13%) in the obese group (n = 102). There was a non-significant difference in the prevalence of low HDL-cholesterolemia between subjects with the G/G genotype (n = 45, 13%) and with the A/A + A/G genotype (15%) in the non-obese group (n = 192). A multivariate-adjusted logistic regression analysis of the presence of low HDL-cholesterolemia revealed that carrying the G/G genotype was an independent and significant factor positively associated with low HDL-cholesterolemia [odds ratio (OR): 6.85, 95% confidence interval (CI): 1.65-28.49] in the obese group, while carrying the G/G genotype exhibited a non-significant but reduced OR, by one-half, for low HDL-cholesterolemia (OR: 0.51, 95% CI: 0.13-1.96) in the non-obese group.
The obesity status could have opposing impacts on the relationship between the G/G genotype and low HDL-cholesterolemia, providing insight into the need to consider the obesity levels when studying the association between the UCP-1 gene A-3826G polymorphism and HDL-cholesterol.
Obesity; Body mass index; HDL-C; Atherosclerotic risk.
有限的研究显示,关于解偶联蛋白1(UCP1)基因A-3826G多态性与高密度脂蛋白(HDL)胆固醇水平之间的关联,数据并不一致。本研究调查了A-3826G多态性与非肥胖和肥胖受试者低HDL胆固醇血症之间的关联。
对294名居住在社区的日本受试者(男/女:127/167,平均年龄:65岁)进行了人体测量和生化指标检测,并通过等位基因特异性DNA检测进行基因分型。肥胖定义为体重指数(BMI)≥25kg/m²,低HDL胆固醇血症定义为HDL胆固醇<1.04mmol/L。
在肥胖组(n = 102)中,G/G基因型受试者(n = 27)的低HDL胆固醇血症患病率(37%)显著高于A/A + A/G基因型受试者(13%)。在非肥胖组(n = 192)中,G/G基因型受试者(n = 45,13%)和A/A + A/G基因型受试者(15%)的低HDL胆固醇血症患病率无显著差异。对低HDL胆固醇血症存在情况进行多变量调整逻辑回归分析显示,在肥胖组中,携带G/G基因型是与低HDL胆固醇血症呈正相关的独立且显著因素[比值比(OR):6.85,95%置信区间(CI):1.65 - 28.49],而在非肥胖组中,携带G/G基因型对低HDL胆固醇血症的OR虽无显著差异,但降低了一半(OR:0.51,95%CI:0.13 - 1.96)。
肥胖状态可能对G/G基因型与低HDL胆固醇血症之间的关系产生相反影响,这为在研究UCP-1基因A-3826G多态性与HDL胆固醇之间的关联时考虑肥胖水平的必要性提供了见解。
肥胖;体重指数;HDL-C;动脉粥样硬化风险